Latest Breaking News On - Canadian institutes for health research - Page 15 : comparemela.com

COVID: Inhaled Canadian vaccine to enter Phase 2 human trials

A new made-in-Canada COVID-19 vaccine that can be inhaled is set to enter Phase 2 human trials.

New brunswickKaren mossmanMatthew millerMcmaster universityCanadian institutes for health researchDalhousie university in nova scotiaUniversity of ottawaCanadian institutesFiona smaillDalhousie universityNova scotia

A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency

A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency
science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.

United statesXin zhenNuevo leóxUnited kingdomFrance generalBritish columbiaMexico cityDistrito federalSan diegoQian zhaoNordrhein westfalenAustralian capital territoryYing wangHarry suttonGherman novakovskyGaetan burgio

Phase 2 Human Trials of Canadian-Made Inhaled COVID Vaccine Set to Begin

A still-developing Canadian COVID-19 vaccine that is delivered by inhaled aerosol rather than an injection is set to enter .

Karen hoganPeter wilsonJean yves duclosUniversity of mcmasterPublic health agency of canadaCanadian institutes for health researchCanadian institutesHealth researchFiona smaillAuditor general karen hoganPublic health agencyMinister jean yves duclosCovid 19 vaccineMcmaster universityThe epoch times

Treatments Help Long-term Outcomes of Critical COVID Illness

Use of interleukin 6 receptor antagonists and antiplatelet agents was associated with better survival rates and higher quality of life at 6 months.

Angela cheungPatrick lawlerAmerican college of cardiologyMedscape coronavirus resource centerMultifactorial adaptive platform for community acquired pneumoniaStroke foundation of canadaUniversity of torontoRapid research fundingResearch instituteCanadian institutes for health researchCanadian institute of health researchCoronavirus resourcePeter munk cardiac centreUniversity health networkMedscape medicalCommunity acquired pneumonia

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial | Critical Care Medicine | JAMA

This secondary analysis of an ongoing adaptive platform trial examines the effect of multiple interventions for critically ill adults with COVID-19 on longer-te

United kingdomSouth australiaFrance generalCity ofBritish columbiaUnited statesWestern australiaSan franciscoNew zealand generalNew zealandEstado de pernambucoNational universityEteläuomen läiSao pauloSri lankaAr riya